Mayer B. Davidson

Aug 29, 2024 | dom-pubs.onlinelibrary.wiley.com | Mayer B. Davidson

LETTER TO THE EDITOR Glycaemic treatment of newly diagnosed type 2 diabetes Mayer B. Davidson MD,  Corresponding Author Mayer B. Davidson MD Charles R. Drew University, California, Los Angeles, USA Correspondence Mayer B. Davidson, MD, Charles R. Drew University, 1731 East 120 Street, Los Angeles, CA 90059, USA. Email: [email protected] for more papers by this author Mayer B. Davidson MD,  Corresponding Author Mayer B. Davidson MD Charles R.

Jun 11, 2024 | dom-pubs.onlinelibrary.wiley.com | Mayer B. Davidson |Charles R. Drew |S. Davidson

No abstract is available for this article. CONFLICT OF INTEREST STATEMENT MBD is the Chief Medical Officer and SJD is the Chief Product Officer of Mellitus Health, Inc. Supporting Information Filename Description dom15679-sup-0001-FigureS1.pdfPDF document, 348.7 KB Figure S1. Report in patient with type 1 diabetes using a Free Style Libre 2 Pro reader (excluding the 96 glucose readings measured every 15 min).

Aug 8, 2023 | jamanetwork.com | Mayer B. Davidson |Charles R. Drew |Justin B. Echouffo-Tcheugui |Leigh Perreault

To the Editor A recent Review1 concluded that prediabetes is associated with an increased risk of cardiovascular disease events.